Investigational New Drugs

  1573-0646

  0167-6997

 

Cơ quản chủ quản:  SPRINGER , Kluwer Academic Publishers

Lĩnh vực:
OncologyPharmacology (medical)Pharmacology

Các bài báo tiêu biểu

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- 2017
Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev, Mitesh J. Borad, Yoon Koo Kang, Jay Stoudemire, Susan Smith, Andreas G. Bader, Sinil Kim, David S. Hong
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Tập 33 Số 1 - Trang 201-214 - 2015
Suzanne Leijen, Sjaak A. Burgers, Paul Baas, Dick Pluim, Matthijs M. Tibben, Erik van Werkhoven, Enzo Alessio, Gianni Sava, Jos H. Beijnen, Jan H.M. Schellens
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
- 2008
Kyle D. Holen, Leonard B. Saltz, Ellen Hollywood, K. Bürk, Axel-Rainer Hanauske
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
- 2014
Erin Dunbar, Bonnie S. Coats, Albert L. Shroads, Taimour Langaee, Alicia Lew, John R. Forder, Jonathan J. Shuster, David Wagner, Peter W. Stacpoole
Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads
Tập 36 Số 1 - Trang 121-135 - 2018
Joanna C. Masters, Dana Nickens, Dawei Xuan, Ronald Shazer, Michael Amantea
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane
- 1995
Tassilo Schilling, K. B. Keppler, Manfred Heim, G. Niebch, Hermann Dietzfelbinger, J. Rastetter, Axel‐R. Hanauske
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
Tập 15 Số 1 - Trang 39-48 - 1997
Yoshihiro Kakeji, Beverly A. Teicher
Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma
Tập 19 Số 1 - Trang 81-83 - 2001
Won Seog Kim, Myung Min Kim, Hong-Jo Choi, Sung‐Soo Yoon, Mark Hong Lee, Keunchil Park, Chan H. Park, Won Ki Kang
Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
- 2010
R. Gollamudi, Mohammad H. Ghalib, Kavita Desai, Imran Chaudhary, Benny Wong, Mark H. Einstein, Matthew Coffey, George M. Gill, K.L. Mettinger, John M. Mariadason, Sridhar Mani, Sanjay Goel